Dr. Benjamin Miller presents at SPIE BiOS 2021, "Photonics-enabled lateral flow assay diagnostics"

Point-of-Care diagnostics are instrumental to patient care and are broadly applied in the clinical setting. The simplest such device is the lateral flow assay, which is used to influence clinical decisions ranging from pregnancy to malarial infection. Lateral flow assays are ubiquitous; however, they are semi-quantitative, require labeled reagents, and are often less sensitive than comparable clinical laboratory technology. We hypothesize that an attractive method to introduce label-free quantification to Point-of-Care diagnostics is to couple them to photonic sensors. Photonic sensors are attractive as biological measurement tools, as they have low size, weight, and power requirements while providing high sensitivity. In this manuscript we describe post-processing of foundry-prepared photonic sensor chips in preparation for integration with a lateral flow format.

Daniel J. Steiner and Benjamin L. Miller, "Photonics-enabled lateral flow assay diagnostics," Proc. SPIE 11662, Frontiers in Biological Detection: From Nanosensors to Systems XIII, 116620F (Presented at SPIE BiOS: 5 March 2021; Published: 5 March 2021); https://doi.org/10.1117/12.2582768

Previous
Previous

SunDensity Signs Research Agreement with University of Rochester Institute of Optics to Further the Manufacturing and Development of its Sustainable Energy Product

Next
Next

ams Invests in New Imaging Center of Excellence in Rochester, NY to Boost Sensor-enabled Consumer Imaging Expertise